However, when assessing survival according to LoY status in KRAS wild‐type and KRAS mutated tumors separately, LoY‐positive patients showed numerically improved OS in the KRAS wild‐type subgroup, although this difference did not reach statistical significance ( p = 0.078; Figure 2D,F ).
← all excerpts
Primary Tumor-Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer.
1
0.0780
0.0780